New research reveals a modest link between COVID-19 infection during pregnancy and increased risk of gestational diabetes, ...

Shionogi’s S-892216 is being developed as a pre-exposure prophylaxis (PrEP) drug for Covid-19. Credit: seksan Mongkhonkhamsao ...

Shionogi will receive $375 million to develop a long-acting protease inhibitor designed to prevent SARS-CoV-2 infection in ...

Vaccination prior to COVID-19 infection does not significantly affect neurological symptoms in patients with postacute sequelae of SARS-CoV-2 infection.

Adriel Chen and Devi Sridhar discuss the outbreak of Paediatric Inflammatory Multisystem Syndrome in 2020 and consider what lessons we can learn In mid-March 2020 and into April 2020, paediatric wards ...

New findings from the NIH RECOVER Initiative suggest that SARS-CoV-2 infection may be associated with an increased risk of ME ...